- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05432895
Dynamic Versus Static Night Splinting of Plantar Fasciitis
August 17, 2026 updated by: Loretta Chou, Stanford University
The investigators are trying to study that there is no difference in improvement of motion between static progressive and dynamic splinting.
Study Overview
Detailed Description
A physical rehabilitation device for the treatment of a medical condition of the foot known as plantar fasciitis includes a splint which is connected to the toe and ankle of a patient.
Static splint is the use of inelastic components to apply torque to a joint in order to statically position it as close to end range as possible.
A dynamic splint uses a tension spring that is integrated into a brace, usually via a mechanical hinge.
The tension spring can be adjusted for more or less tension to achieve range of motion goals with less pain.
The investigators are trying to study that there is no difference in improvement of motion between static progressive and dynamic splinting.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94063
- Stanford University School of Medicine
-
Redwood City, California, United States, 84063
- Stanford outpatient center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Demographic - Over 18 years of age and ambulatory without a gait aid with no history of narcotic use
- Diagnosis - Unilateral or bilateral acute (< 6 months of pain) plantar fasciitis (i.e., Heel pain that increases with weightbearing, "First step pain": heel pain that occurs after a period of non-weightbearing, such as in the morning when arising from bed or when arising after prolonged sitting; the pain is improved after a few minutes walking but will worsen again with prolonged weightbearing, tenderness over the medial calcaneal tuberosity at the insertion of the plantar fasciitis)
- Permitted - Icing, NSAIDS( ibuprofen), Custom Shoe Inserts, Diagnostic Ultrasound
Exclusion Criteria:
- Demographic - Under 18 year of age, requires a gait aid for ambulation; if not covered by insurance,
- Diagnosis of - Arthritis of the Ankle, Midfoot, or Forefoot; Inflammatory Arthritis; Gout; Turf Toe; Hallux Rigidus; Hallux Limitus; Sesamoiditis; Tendonitis or Tendinopathy; Prior tear or Rupture of the Plantar Fascia; Fibromyalgia, Neuralgia, or Neuropathy; Peripheral Vascular Disease; Prior Trauma to the Heel, Fracture of the Calcaneus; Infection; Corn; Callus; Ingrown Nail.
- Patient with history of Symptoms for over 6 months
- Refractory to prior splint-based treatments
- Prior injection of the plantar fascia
- Prior surgery on the plantar fascia
- Narcotic use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control( static splinting)
conventional static splint
|
Device treats plantar fasciitis and replacing boot immobilization which is quite benign
|
|
Experimental: Experiment( dynamic splinting)
Device treats plantar fasciitis and replacing boot immobilization
|
Device treats plantar fasciitis and replacing boot immobilization which is quite benign
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NO Pain at 1 Month Follow up
Time Frame: 1 months
|
Pain measured on a visual analog scale (VAS): score range: 0 (no pain) to 10 (worst pain)
|
1 months
|
|
NO Pain at 3 Months Follow up
Time Frame: 3 months
|
Pain measured on a VAS: score range: 0 (no pain) to 10 (worst pain)
|
3 months
|
|
NO Pain at 6 Months Follow up
Time Frame: 6 months
|
Pain measured on a VAS: score range: 0 (no pain) to 10 (worst pain)
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Foot Function Index (FFI) Score
Time Frame: 1 month
|
The FFI asks a series of 17 questions related to foot function, each rated on a scale of 1 to 10, which are summed and averaged to create an overall score of 1 to 10 (for both the subscale and overall scores, higher scores correspond to worse symptoms).
|
1 month
|
|
Foot Function Index (FFI)
Time Frame: 3 months
|
The FFI asks a series of 17 questions related to foot function, each rated on a scale of 1 to 10, which are summed and averaged to create an overall score of 1 to 10 (for both the subscale and overall scores, higher scores correspond to worse symptoms).
|
3 months
|
|
Foot Function Index (FFI)
Time Frame: 6 months
|
The FFI asks a series of 17 questions related to foot function, each rated on a scale of 1 to 10, which are summed and averaged to create an overall score of 1 to 10 (for both the subscale and overall scores, higher scores correspond to worse symptoms).
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 31, 2023
Primary Completion (Actual)
January 30, 2025
Study Completion (Actual)
January 30, 2025
Study Registration Dates
First Submitted
May 4, 2022
First Submitted That Met QC Criteria
June 22, 2022
First Posted (Actual)
June 27, 2022
Study Record Updates
Last Update Posted (Actual)
September 9, 2026
Last Update Submitted That Met QC Criteria
August 17, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60879
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.